La vacuna contra la influenza: una nueva herramienta de prevención cardiovascular

Autores/as

DOI:

https://doi.org/10.24265/horizmed.2020.v20n3.01%20

Palabras clave:

Orthomyxoviridae

Descargas

Los datos de descargas todavía no están disponibles.

Citas

Ruiz-Mori E. Riesgo y Prevención Cardiovascular. Unigraph. Lima; 2014.

Kurihara O, Takano M, Yamamoto E, Yonetsu T, Kakuta T, Soeda T, et al. Seasonal Variations in the Pathogenesis of Acute Coronary Syndromes. J Am Heart Assoc. 2020; 9(13): e015579.

Finelli L, Chaves S. Influenza and acute myocardial infarction. J Infect Dis. 2011; 203(12): 1701-4.

Warren-Gash C, Smeeth L, Hayward AC. Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review. Lancet Infect Dis. 2009; 9(10): 601-10.

Centers for Disease Control and Preventions. Past Seasons Estimated Influenza Disease Burden [Internet]. 2020. Disponible en: https://www. cdc.gov/flu/about/burden/past-seasons.html

Musher D, Abers M, Corrales-Medina V. Acute Infection and Myocardial Infarction. N Engl J Med. 2019; 380(2): 171-6.

Nguyen JL, Yang W, Ito K, Matte TD, Shaman J, Kinney PL. Seasonal Influenza Infections and Cardiovascular Disease Mortality. JAMA Cardiol. 2016; 1(3): 274-81.

Blackburn RM, Zhao H, Pebody R, Hayward AC, Warren-Gash C. Laboratory-confirmed respiratory infections as predictors of hospital admission for myocardial infarction and stroke: time-series analysis of English data for 2004–2015. Clin Infect Dis. 2018; 67(1): 8-17.

Udell JA, Zawi R, Bhatt DL, Keshtkar-Jahromi M, Gaughran F, Phrommintikul A, et al. Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis. JAMA. 2013; 310: 1711-20.

Aguado T, Barratt J, Beard J, Blomberg B, Chen H, Hickling J, et al. Report on WHO meeting on immunization in older adults: Geneva, Switzerland, 22-23 March 2017. Vaccine. 2018; 36(7): 921-31.

Ortiz J, Hickling J, Jones R, Donabedian A, Engelhardt O,Katz J,et al. Report on eighth WHO meeting on development of influenza vaccines that induce broadly protective and long-lasting immune responses: Chicago, USA, 23–24 August 2016. Vaccine. 2018; 36(7): 932-8.

##submission.downloads##

Publicado

2020-10-07

Cómo citar

Lizaraso Caparó, F., & Ruiz-Mori, E. (2020). La vacuna contra la influenza: una nueva herramienta de prevención cardiovascular. Horizonte Médico (Lima), 20(3), e1316. https://doi.org/10.24265/horizmed.2020.v20n3.01

Artículos más leídos del mismo autor/a

1 2 3 4 > >>